Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma
Latest Information Update: 07 Jan 2019
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 08 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 08 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 28 Dec 2016 Planned End Date changed from 1 Dec 2014 to 1 Dec 2016.